MORGAN STANLEY PLC/CALL/MERCK & CO./180/0.1/19.12.25 Share Price

Warrant

DE000ME7L5K9

Market Closed - Börse Stuttgart 12:16:41 27/06/2024 am IST
0.34 EUR 0.00% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./180/0.1/19.12.25
Current month+55.25%
1 month+30.77%
Date Price Change
26/24/26 0.34 0.00%
25/24/25 0.34 +6.25%
24/24/24 0.32 +10.34%
21/24/21 0.29 +7.41%
20/24/20 0.27 +12.50%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 12:16 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN ME7L5K
ISINDE000ME7L5K9
Date issued 25/01/2024
Strike 180 $
Maturity 19/12/2025 (541 Days)
Parity 10 : 1
Emission price 0.16
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.42
Lowest since issue 0.168
Spread 0.01
Spread %2.94%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.5 USD
Average target price
142.7 USD
Spread / Average Target
+8.50%
Consensus